Snowball logo
logo
MDGL_logo

Madrigal Pharmaceuticals, Inc

$444.83+$6.10  (1.39%)

Frequently asked questions

What sector does Madrigal Pharmaceuticals, Inc (MDGL) operate in?

Madrigal Pharmaceuticals, Inc belongs to the Healthcare sector and operates in the Biotechnology industry.

What is Madrigal Pharmaceuticals, Inc (MDGL) current stock price?

As of the latest data, Madrigal Pharmaceuticals, Inc stock price is $444.83, with a previous close of $438.73. Madrigal Pharmaceuticals, Inc gained $6.10 in the last trading session, representing a 1.39% increase.

What is Madrigal Pharmaceuticals, Inc (MDGL) current market capitalization?

Madrigal Pharmaceuticals, Inc market cap is approximately 10.10 billion.

What is Madrigal Pharmaceuticals, Inc (MDGL) Earnings Per Share (EPS)?

The trailing EPS is -$12.91, and the forward EPS is $2.35.

What is Madrigal Pharmaceuticals, Inc (MDGL) EBITDA?

Madrigal Pharmaceuticals, Inc EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -106.38 million.

Does Madrigal Pharmaceuticals, Inc (MDGL) pay dividends?

No. Madrigal Pharmaceuticals, Inc does not pay a dividend.

How did Madrigal Pharmaceuticals, Inc (MDGL) perform in its most recent earnings report?

In the last report (December 31, 2025), Madrigal Pharmaceuticals, Inc posted an EPS surprise of -47.49% and a revenue surprise of 15.97%.

When is Madrigal Pharmaceuticals, Inc (MDGL) next earnings report?

Madrigal Pharmaceuticals, Inc is expected to release its next earnings report on March 31, 2026.

What is Madrigal Pharmaceuticals, Inc (MDGL) beta (volatility) score?

Madrigal Pharmaceuticals, Inc has a beta of -1.019, indicating lower volatility than the overall market.